FDA Inspection
Cipla LimitedCipla Limited – FDA Inspection, Sep 28, 2018
Record Details
This FDA Inspection record concerns Cipla Limited, with an inspection on September 28, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Nicole E. Knowlton (FDA Associated Person)
- Pei-I Chu (Issuing Officer)
- Rebecca E. Dowd (FDA Associated Person)
View Company Profile
ID · fd66a0e6-fa12-4219-bb1a-572cd01b3c0f
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1069950
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Cipla Limited
13| Date | Classification | Office | Project area |
|---|---|---|---|
| April 17, 2026 | Not classified | Office of Inspections and Investigations | Drug Quality Assurance |
| June 21, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 26, 2022 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 27, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 28, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Cipla Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.